J Natl Cancer Inst. 2012 Aug 22;104(16):1264; author reply 1266-8. doi: 10.1093/jnci/djs304. Epub 2012 Jul 31.

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.

Nakamura Y, Ratain MJ, Cox NJ, McLeod HL, Kroetz DL, Flockhart DA.

Comment on

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial. [J Natl Cancer Inst. 2012]
CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.Regan MM, Leyland-Jones B, Bouzyk M, Pagani O, Tang W, Kammler R, Dell'orto P, Biasi MO, Thürlimann B, Lyng MB, et al. J Natl Cancer Inst. 2012 Mar 21; 104(6):441-51. Epub 2012 Mar 6.
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. [J Natl Cancer Inst. 2012]
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.Rae JM, Drury S, Hayes DF, Stearns V, Thibert JN, Haynes BP, Salter J, Sestak I, Cuzick J, Dowsett M, et al. J Natl Cancer Inst. 2012 Mar 21; 104(6):452-60. Epub 2012 Mar 6.
CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: lessons learned. [J Natl Cancer Inst. 2012]
CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: lessons learned.Kelly CM, Pritchard KI. J Natl Cancer Inst. 2012 Mar 21; 104(6):427-8. Epub 2012 Mar 6.

PMID:: 22851270; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Breast Cancer - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial. [J Natl Cancer Inst. 2012]
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
Stanton V Jr. J Natl Cancer Inst. 2012 Aug 22; 104(16):1265-6; author reply 1266-8. Epub 2012 Jul 31.
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. [J Natl Cancer Inst. 2012]
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.
Pharoah PD, Abraham J, Caldas C. J Natl Cancer Inst. 2012 Aug 22; 104(16):1263-4; author reply 1266-8. Epub 2012 Jul 31.
CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: lessons learned. [J Natl Cancer Inst. 2012]
CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: lessons learned.
Kelly CM, Pritchard KI. J Natl Cancer Inst. 2012 Mar 21; 104(6):427-8. Epub 2012 Mar 6.
Review Never too late: reducing late breast cancer relapse risk. [Curr Med Res Opin. 2008]
Review Never too late: reducing late breast cancer relapse risk.
Harbeck N. Curr Med Res Opin. 2008 Dec; 24(12):3295-305.
Review Overcoming recurrence risk: extended adjuvant endocrine therapy. [Clin Breast Cancer. 2008]
Review Overcoming recurrence risk: extended adjuvant endocrine therapy.
Cianfrocca M. Clin Breast Cancer. 2008 Dec; 8(6):493-500.

See reviews... See all...

Cited by 3 PubMed Central articles

Applications of CYP450 Testing in the Clinical Setting. [Mol Diagn Ther. 2013]
Applications of CYP450 Testing in the Clinical Setting.
Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA. Mol Diagn Ther. 2013 Jun; 17(3):165-84.
Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study. [Int J Mol Epidemiol Genet. 2013]
Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.
Brooks JD, Teraoka SN, Malone KE, Haile RW, Bernstein L, Lynch CF, Mellemkjær L, Duggan DJ, Reiner AS, Concannon P, et al. Int J Mol Epidemiol Genet. 2013; 4(1):35-48. Epub 2013 Mar 18.
Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice. [ISRN Pharmacol. 2013]
Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.
Lam YW. ISRN Pharmacol. 2013; 2013:641089. Epub 2013 Feb 28.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrin...
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
J Natl Cancer Inst. 2012 Aug 22 ;104(16):1264; author reply 1266-8. doi: 10.1093/jnci/djs304. Epub 2012 Jul 31 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information